Jan 15, 2026
Most ViewedHow do SGLT2 inhibitors reduce cardiovascular and renal risk in people with type 2 diabetes?
SGLT2 inhibitors reduce cardiovascular and renal risk in type 2 diabetes through a combination of renal hemodynamic effects, systemic metabolic shifts, and direct cardiac and vascular actions that go ...